Recombinant myonectin ameliorates sepsis-induced cardiomyopathy by alleviating mitochondrial dysfunction via the AdipoR1/AMPK pathway

Peipei Li, Rui Chen, Hanmo Zhang, Lihong Li, Huiling Luo, Beibei Du, Ping Yang · 2026

Read Recombinant myonectin ameliorates sepsis-induced cardiomyopathy by alleviating mitochondrial dysfunction via the AdipoR1/AMPK pathway by Peipei Li, Rui Chen, Hanmo Zhang, Lihong Li, Huiling Luo, Beibei Du, Ping Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13314204.txt.

Description

Peipei Li and colleagues test a muscle-made protein against sepsis damage to the heart in work published in 2026. Sepsis often weakens the heart muscle, a state with high death rates and no good therapy, and failing mitochondria sit at the center of the harm.

The protein, myonectin, also named CTRP15, guards the heart in other settings by calming inflammation, cell death, and scarring. The team made a lab-built form and gave it to mice before sepsis was induced by bacterial toxin or by gut puncture, and to newborn mouse heart cells in dishes. They then checked heart function and cell energy health, tracing the effect through the AdipoR1 and AMPK path named in the title. The work tests whether topping up a natural heart guard can shield the heart during sepsis.

Catalog record

CREATORPeipei Li, Rui Chen, Hanmo Zhang, Lihong Li, Huiling Luo, Beibei Du, Ping Yang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43272
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13314204

Browse the full library · About the Tower of Babel